Home > Journals > Minerva Gastroenterology > Past Issues > Minerva Gastroenterology 2022 September;68(3) > Minerva Gastroenterology 2022 September;68(3):344-6

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   Free accessfree

Minerva Gastroenterology 2022 September;68(3):344-6

DOI: 10.23736/S2724-5985.21.02908-9

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

LncRNA TMPO-AS1 promotes hepatocellular carcinoma progression via activating PI3K-AKT pathway

Huan YE 1, Chenchen ZHANG 2, Zhengcai LI 3

1 Department of Hepatopancreatobiliary Surgery, Wuhan Puren Hospital, Wuhan, China; 2 Department of Hepatobiliary Surgery, Wuhan N.1 Hospital, Wuhan, China; 3 Department of General Surgery, Jingmen Hospital of Traditional Chinese Medicine, Jingmen, China



top of page